Johnson & Johnson (JNJ) News 97.44 $JNJ
Finding a Niche for Celgene's Otezla
Brian Orelli, The Motley Fool - Motley Fool - 9 mins ago
Celgene 's new psoriatic arthritis drug Otezla isn't going to beat the current offerings from AbbVie , Johnson & Johnson , and Amgen on an efficacy basis. But it doesn't have too. Unlike Humira, Remicade, Enbrel, and the rest of the...
Don't Underestimate J&J's Best-Known Products
Peter Stephens, The Motley Fool - Motley Fool - Fri Mar 28, 5:30PM CDT
Despite being one of the major pharma stocks in the world, J&J is a very diversified company. For instance, the consumer segment accounts for a significant proportion of revenue and, as such, is a key component of future returns for the stock....
Final Glance: Pharmaceuticals companies
AP - Fri Mar 28, 5:02PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Fri Mar 28, 5:02PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Fri Mar 28, 12:32PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Fri Mar 28, 12:32PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are up at 1 p.m.:
VisionCare Announces Management Promotions
PR Newswire - Fri Mar 28, 10:00AM CDT
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration, today announced two promotions within its management team. Chet Kumar has been appointed Vice President, Sales & Market Development; Mr. Kumar most recently was the Company's Vice President, Market & Business Development.
Early Glance: Pharmaceuticals companies
AP - Fri Mar 28, 9:23AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 10 a.m.:
Early Glance: Medical Devices companies
AP - Fri Mar 28, 9:23AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are up at 10 a.m.:
Exelixis Inc's Comet Fails To Dazzle
Stephen D., Simpson,, The Motley Fool - Motley Fool - Fri Mar 28, 8:30AM CDT
Astronomers have grown very cautious over the years about predicting which comets will brighten the night skies, as all too many have failed to live up to expectation. Small biotech Exelixis ' own comet, the COMET-1 study of cabozantinib in...
IR professionals converge on New York City for 19th annual IR Magazine Awards - US
PR Newswire - Fri Mar 28, 8:00AM CDT
Covidien has made it another year to remember after winning the grand prix for best overall IR by a large-cap company for the fourth year in a row at the IR Magazine Awards - US 2014. The medical equipment maker's head of IR, Cole Lannum, also picked up his fourth consecutive award for best IRO at a large cap. For the full list of all winners, please see below.
Global Immunoassay Systems Market 2012-2016: Limited Reimbursements Could Pose a Challenge to the Growth of this Market
M2 - Fri Mar 28, 7:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c9bs77/global) has announced the addition of the "Global Immunoassay Systems Market 2012-2016" report to their offering. The analysts forecast the Global Immunoassay Systems market to grow at a CAGR of 3.92 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased prevalence of chronic diseases worldwide. The Global Immunoassay Systems market has also been witnessing a growing popularity of portable immunoassays. However, li. The key vendors dominating this market space include Abbott Laboratories, Danaher Corp., Roche Holding Ltd., and Siemens Healthcare Diagnostics Inc. The other vendors mentioned in the report are BioMerieux SA, BiOptic Inc., Bio-Rad Laboratories Inc., Fujirebio Inc., Johnson and Johnson, PerkinElmer Inc., and Trinity Biotech plc. Commenting on the report, an analyst from the Healthcare team said: The Global Immunoassay Systems market has been witnessing a spate of mergers and acquisitions by leading vendors. These mergers and acquisitions have helped vendors increase their global presence, prevent the loss of patents, and achieve economies of scale. For instance, Danaher Corp. acquired Beckman Coulter Inc. in 2011. It also acquired IRIS International Inc., a manufacturer of automated IVD systems in November 2012. These mergers and acquisitions will strengthen its position in the Global Immunoassay Systems market. Further, merger and acquisition activities by the leading vendors will enable them to develop a variety of offerings for the Global Immunoassay Systems market, which will boost their revenue during the forecast period. The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are bioMerieux SA, Bio-Rad Laboratories Inc., PerkinElmer Inc., BiOptic Inc., Fujirebio Inc., and Trinity Biotech plc. For more information visit http://www.researchandmarkets.com/research/c9bs77/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Positive Opinions, Presentation Schedules of Investigational Data, Clinical Study Results, and Stock Price Movements - Analyst Notes on Johnson & Johnson, Merck, Pfizer, Amgen, and Allergan
PR Newswire - Fri Mar 28, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Johnson & Johnson (NYSE: JNJ), Merck & Co. Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE), Amgen Inc. (NASDAQ: AMGN), and Allergan Inc. (NYSE: AGN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Endoscopy Market Report: 2014 Edition
M2 - Fri Mar 28, 5:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ww97b8/global_endoscopy) has announced the addition of the "Global Endoscopy Market Report: 2014 Edition" report to their offering. Due to these multiple uses, the enodoscopy market continues to grow worldwide. The development of technologically advanced endoscopic equipments in the US, Europe and Japan has resulted in steep market growth of endoscopic products in these regions, while diffusion of these products in emerging countries like China and India has just started. However, these emerging economies hold great opportunities for endoscopy market growth due to increasing income levels and improving medical infrastructure. Factors like growing ageing demographics, increasing income levels, and rising incidence rate of other co-morbidities like obesity and diabetes are driving endoscopy market. In addition, the demand for endoscopic equipments is being increasingly driven by rising incidences of cancer cases due to their growing usage for early detection and treatment of the disease. The increasing number of endoscopic procedures due to growing preference for minimally invasive surgeries is likely to further propel the growth of the industry. The market is projected to grow further in years to come and become more specialized due to economic, social and demographic trends. The market for endoscopy products is highly competitive with several players operating both at a global and regional level. Technological, price, and service diversities are the key factors responsible for driving competition in the market. Key Topics Covered 1. Market Overview 1.1 Introduction 1.2 Use of Endoscopy 1.3 Types of Endoscopes 2. Market Size 2.1 Global Endoscopy Market 2.2 Market Segments by Application 2.3 Market Segments by Technology 3. Market Dynamics 3.1 Key Trends 3.2 Growth Drivers 3.3 Challenges 3.4 Significant developments 4. Competitive Landscape 4.1 Overall Endoscopy Market 4.2 Flexible Endoscope Market 4.3 Surgical Endoscope Market 5. Company Profiles 6. Market Outlook 6.1 Market Forecast 6.2 Forecast Methodology Companies Mentioned - Boston Scientific - Covidien - Johnson & Johnson - Olympus For more information visit http://www.researchandmarkets.com/research/ww..._endoscopy
Stock-Pickers' Market Returns
at The Street - Fri Mar 28, 5:25AM CDT
It's not a cliche; we're actually entering a stock-pickers' market again!
Can AbbVie's Legacy Products Deliver Further Growth?
David Phillips, The Motley Fool - Motley Fool - Thu Mar 27, 5:30PM CDT
AbbVie is spending more than 16% of annual sales to develop a pipeline -- including promising treatments for multiple sclerosis, blood cancers, and hepatitis-C (across all patient types) -- with the goal of reducing its dependence on the...
Is It Time to Buy These 2 Cancer-Fighting Companies?
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 27, 4:42PM CDT
Investors shouldn't buy and sell shares on market whims and whispers. After all, markets can jump up and down when we least expect it, and that means the chances for predicting its direction over a short period of time is a coin flip, at best. ...
Business Highlights
By The Associated Press - AP - Thu Mar 27, 4:29PM CDT
___
Finding a Niche for Celgene's Otezla
Brian Orelli, The Motley Fool - Motley Fool - 9 mins ago
Celgene 's new psoriatic arthritis drug Otezla isn't going to beat the current offerings from AbbVie , Johnson & Johnson , and Amgen on an efficacy basis. But it doesn't have too. Unlike Humira, Remicade, Enbrel, and the rest of the...
Don't Underestimate J&J's Best-Known Products
Peter Stephens, The Motley Fool - Motley Fool - Fri Mar 28, 5:30PM CDT
Despite being one of the major pharma stocks in the world, J&J is a very diversified company. For instance, the consumer segment accounts for a significant proportion of revenue and, as such, is a key component of future returns for the stock....
Final Glance: Pharmaceuticals companies
AP - Fri Mar 28, 5:02PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Fri Mar 28, 5:02PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Fri Mar 28, 12:32PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Fri Mar 28, 12:32PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are up at 1 p.m.:
VisionCare Announces Management Promotions
PR Newswire - Fri Mar 28, 10:00AM CDT
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration, today announced two promotions within its management team. Chet Kumar has been appointed Vice President, Sales & Market Development; Mr. Kumar most recently was the Company's Vice President, Market & Business Development.
Early Glance: Pharmaceuticals companies
AP - Fri Mar 28, 9:23AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 10 a.m.:
Early Glance: Medical Devices companies
AP - Fri Mar 28, 9:23AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are up at 10 a.m.:
Exelixis Inc's Comet Fails To Dazzle
Stephen D., Simpson,, The Motley Fool - Motley Fool - Fri Mar 28, 8:30AM CDT
Astronomers have grown very cautious over the years about predicting which comets will brighten the night skies, as all too many have failed to live up to expectation. Small biotech Exelixis ' own comet, the COMET-1 study of cabozantinib in...
IR professionals converge on New York City for 19th annual IR Magazine Awards - US
PR Newswire - Fri Mar 28, 8:00AM CDT
Covidien has made it another year to remember after winning the grand prix for best overall IR by a large-cap company for the fourth year in a row at the IR Magazine Awards - US 2014. The medical equipment maker's head of IR, Cole Lannum, also picked up his fourth consecutive award for best IRO at a large cap. For the full list of all winners, please see below.
Global Immunoassay Systems Market 2012-2016: Limited Reimbursements Could Pose a Challenge to the Growth of this Market
M2 - Fri Mar 28, 7:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c9bs77/global) has announced the addition of the "Global Immunoassay Systems Market 2012-2016" report to their offering. The analysts forecast the Global Immunoassay Systems market to grow at a CAGR of 3.92 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased prevalence of chronic diseases worldwide. The Global Immunoassay Systems market has also been witnessing a growing popularity of portable immunoassays. However, li. The key vendors dominating this market space include Abbott Laboratories, Danaher Corp., Roche Holding Ltd., and Siemens Healthcare Diagnostics Inc. The other vendors mentioned in the report are BioMerieux SA, BiOptic Inc., Bio-Rad Laboratories Inc., Fujirebio Inc., Johnson and Johnson, PerkinElmer Inc., and Trinity Biotech plc. Commenting on the report, an analyst from the Healthcare team said: The Global Immunoassay Systems market has been witnessing a spate of mergers and acquisitions by leading vendors. These mergers and acquisitions have helped vendors increase their global presence, prevent the loss of patents, and achieve economies of scale. For instance, Danaher Corp. acquired Beckman Coulter Inc. in 2011. It also acquired IRIS International Inc., a manufacturer of automated IVD systems in November 2012. These mergers and acquisitions will strengthen its position in the Global Immunoassay Systems market. Further, merger and acquisition activities by the leading vendors will enable them to develop a variety of offerings for the Global Immunoassay Systems market, which will boost their revenue during the forecast period. The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are bioMerieux SA, Bio-Rad Laboratories Inc., PerkinElmer Inc., BiOptic Inc., Fujirebio Inc., and Trinity Biotech plc. For more information visit http://www.researchandmarkets.com/research/c9bs77/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Positive Opinions, Presentation Schedules of Investigational Data, Clinical Study Results, and Stock Price Movements - Analyst Notes on Johnson & Johnson, Merck, Pfizer, Amgen, and Allergan
PR Newswire - Fri Mar 28, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Johnson & Johnson (NYSE: JNJ), Merck & Co. Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE), Amgen Inc. (NASDAQ: AMGN), and Allergan Inc. (NYSE: AGN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Endoscopy Market Report: 2014 Edition
M2 - Fri Mar 28, 5:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ww97b8/global_endoscopy) has announced the addition of the "Global Endoscopy Market Report: 2014 Edition" report to their offering. Due to these multiple uses, the enodoscopy market continues to grow worldwide. The development of technologically advanced endoscopic equipments in the US, Europe and Japan has resulted in steep market growth of endoscopic products in these regions, while diffusion of these products in emerging countries like China and India has just started. However, these emerging economies hold great opportunities for endoscopy market growth due to increasing income levels and improving medical infrastructure. Factors like growing ageing demographics, increasing income levels, and rising incidence rate of other co-morbidities like obesity and diabetes are driving endoscopy market. In addition, the demand for endoscopic equipments is being increasingly driven by rising incidences of cancer cases due to their growing usage for early detection and treatment of the disease. The increasing number of endoscopic procedures due to growing preference for minimally invasive surgeries is likely to further propel the growth of the industry. The market is projected to grow further in years to come and become more specialized due to economic, social and demographic trends. The market for endoscopy products is highly competitive with several players operating both at a global and regional level. Technological, price, and service diversities are the key factors responsible for driving competition in the market. Key Topics Covered 1. Market Overview 1.1 Introduction 1.2 Use of Endoscopy 1.3 Types of Endoscopes 2. Market Size 2.1 Global Endoscopy Market 2.2 Market Segments by Application 2.3 Market Segments by Technology 3. Market Dynamics 3.1 Key Trends 3.2 Growth Drivers 3.3 Challenges 3.4 Significant developments 4. Competitive Landscape 4.1 Overall Endoscopy Market 4.2 Flexible Endoscope Market 4.3 Surgical Endoscope Market 5. Company Profiles 6. Market Outlook 6.1 Market Forecast 6.2 Forecast Methodology Companies Mentioned - Boston Scientific - Covidien - Johnson & Johnson - Olympus For more information visit http://www.researchandmarkets.com/research/ww..._endoscopy
Stock-Pickers' Market Returns
at The Street - Fri Mar 28, 5:25AM CDT
It's not a cliche; we're actually entering a stock-pickers' market again!
Can AbbVie's Legacy Products Deliver Further Growth?
David Phillips, The Motley Fool - Motley Fool - Thu Mar 27, 5:30PM CDT
AbbVie is spending more than 16% of annual sales to develop a pipeline -- including promising treatments for multiple sclerosis, blood cancers, and hepatitis-C (across all patient types) -- with the goal of reducing its dependence on the...
Is It Time to Buy These 2 Cancer-Fighting Companies?
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 27, 4:42PM CDT
Investors shouldn't buy and sell shares on market whims and whispers. After all, markets can jump up and down when we least expect it, and that means the chances for predicting its direction over a short period of time is a coin flip, at best. ...
Business Highlights
By The Associated Press - AP - Thu Mar 27, 4:29PM CDT
___
